ASCEND BY NTHRYS
Research Abroad Products

Biomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Multimodal Biomarker Integration Platform for Clinical Decisions
Sophisticated analytics tool combining genomic, proteomic, and imaging biomarkers into unified patient risk scores and treatment recommendations. Monetizes through white-label licensing to hospitals, EHR integration partnerships, and outcomes-based pricing models tied to improved patient results.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Immunological Biomarker Profiling Commercial Testing Service
Specialized diagnostic service measuring immune checkpoint markers and immunogenicity predictors to optimize cancer immunotherapy selection and dosing. Captures revenue through CPT coding reimbursement, volume-based contracts with oncology centers, and pharmaceutical sponsor-funded biomarker studies.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Predictive Biomarker Validation Software for Clinical Trials
Regulatory-compliant platform automating biomarker qualification, co-development documentation, and FDA submissions for companion diagnostics and stratified medicine programs. Generates recurring licensing fees from CROs and pharmaceutical companies while reducing time-to-regulatory-approval by 40 percent.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Epigenetic Biomarker Discovery Platform for Cancer Screening
Proprietary technology platform identifying DNA methylation and histone modification patterns as early cancer detection biomarkers with minimal invasiveness. Delivers revenue through diagnostic kit sales, laboratory service contracts, and licensing deals with in vitro diagnostics manufacturers targeting screening markets.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Exosomal Biomarker Isolation and Analysis Commercial Solution
Integrated hardware and software system enabling rapid isolation and characterization of disease-specific exosomes and extracellular vesicle biomarkers. Monetizes through equipment sales, consumable subscriptions, and data interpretation services supporting oncology, neurology, and cardiovascular diagnostics.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Machine Learning Biomarker Phenotyping Platform for Precision Medicine
Advanced AI platform that discovers patient-specific biomarker combinations predicting therapy response and adverse events for personalized treatment optimization. Creates enterprise value through healthcare system licensing, pharmaceutical collaboration agreements, and performance-based revenue linked to improved clinical outcomes and reduced hospitalizations.
Biomics Clinical Biomarker Discovery Platforms Click to view more details →
Multi-Omics Integration Platform for Drug Response Prediction
A SaaS platform that integrates genomics, proteomics, metabolomics, and transcriptomics data to predict patient-specific drug responses and treatment outcomes. This enables pharmaceutical companies to accelerate personalized medicine development and reduce clinical trial failure rates by 30-40%.
Systems-Level Biomics Analytics for Pharma Click to view more details →
Real-Time Biomarker Discovery Engine for Clinical Trials
An AI-powered analytics tool that identifies and validates predictive biomarkers from multi-dimensional patient data during ongoing clinical trials. This reduces time-to-market for companion diagnostics and enables sponsors to optimize patient stratification, directly improving trial success rates and regulatory approval odds.
Systems-Level Biomics Analytics for Pharma Click to view more details →
Pathway-Level Systems Pharmacology Analytics Dashboard
A commercial software suite that maps drug-target interactions across biological pathways using systems-level modeling and real-time data integration. This delivers quantified off-target risk assessment and mechanism-of-action clarity, reducing late-stage safety failures and accelerating regulatory submissions.
Systems-Level Biomics Analytics for Pharma Click to view more details →
Population Genomics Intelligence Platform for Precision Dosing
A cloud-based platform that analyzes population-level genetic variations to predict optimal dosing strategies and adverse event risk across diverse demographics. This monetizes through licensing to pharmaceutical companies for precision medicine label claims and enables post-market pharmacogenomic optimization.
Systems-Level Biomics Analytics for Pharma Click to view more details →
Synthetic Patient Cohort Generation and Simulation Suite
An enterprise tool that generates realistic synthetic patient populations based on real-world biomics data, enabling in silico trial design and virtual cohort validation before physical recruitment. This reduces recruitment costs by 25-35% and accelerates patient matching for adaptive trial designs.
Systems-Level Biomics Analytics for Pharma Click to view more details →
Real-World Evidence Integration System for Post-Market Surveillance
A HIPAA-compliant SaaS platform that aggregates and analyzes genomics, phenotypics, and clinical outcome data from real-world sources to monitor drug safety and efficacy post-launch. This generates continuous real-world evidence streams that support label extensions, lifecycle management, and competitive advantage.
Systems-Level Biomics Analytics for Pharma Click to view more details →